Gail Garland, OBIO CEO talks with BNN about the economic and health benefits that accrue to Canada by building a globally competitive Canadian health science industry. Click here for the full interview.
OBIO Globe & Mail Op-Ed: Canada needs a strategy to reach its biotech potential
OBIO® Strategic Review: August 2015
They always say time changes things, but you actually have to change them yourself.
Andy Warhol
2015 has been a year of growth and opportunity for OBIO with expanding networks and new partnerships. Since we released our five year strategic review in January 2015, there have been significant developments both within our walls and across the ecosystem.
OBIO / OBEST Five Year Strategic Review
“The best way to predict the future is to create it”
Peter Drucker
Since its founding in 2009, the Ontario Bioscience Innovation Organization (OBIO®) has been engaged in creating the future of Ontario’s biomedical sector through industry-led strategy, policy development, advocacy and high impact programming. OBIO pursues innovative thought leadership within a culture of trust, reaching out to ever growing circles of thinkers and stakeholders.
Biotechnology Focus article: OBIO® receives investment from the government of Canada to boost investment opportunities and strengthen innovation for Ontario’s commercial bioscience cluster
On May 22, 2015, Member of Parliament for Don Valley West John Carmichael, along with Member of Parliament for Etobicoke-Lakeshore Bernard Trottier announced an investment of up to $3.894 million to support the Ontario Bioscience Innovation Organization’s (OBIO®) efforts to boost investment opportunities for Ontario companies and strengthen innovation for Ontario’s
commercial bioscience cluster.
OBEST Strategic Implementation Plan
Over the past several months, OBESTTM has engaged >200 senior representatives from major stakeholder groups across Ontario’s life-sciences sector. The 6-month strategic planning process has resulted in defined priorities and a plan for robust growth and commercial viability of the province’s bioscience industry.